Which antibiotics are commonly used for atypical pneumonia such as Mycoplasma or Chlamydophila?

• A. Beta-lactams like penicillin only.
• B. Macrolides or doxycycline may be used.
• C. Fluoroquinolones are never used.
• D. Antivirals are first-line.

Answer: (B)

Atypical pneumonia pathogens like Mycoplasma pneumoniae and Chlamydophila pneumoniae behave differently from typical bacterial causes, so they don’t respond to the usual beta-lactam antibiotics. Mycoplasma has no cell wall, which is exactly what beta-lactams target, so penicillins and related drugs are ineffective. Chlamydophila is an intracellular organism, and many beta-lactams don’t reach intracellular bacteria well. The antibiotics that do work against these organisms are ones that can either penetrate cells effectively or inhibit protein synthesis in the bacteria.

Macrolides and doxycycline fit this need. Macrolides, such as azithromycin or clarithromycin, bind the 50S ribosomal subunit and block protein synthesis, with good intracellular penetration, making them effective against these atypical pathogens. Doxycycline, a tetracycline, binds the 30S ribosomal subunit and also penetrates cells well, providing reliable activity against Mycoplasma and Chlamydophila. While fluoroquinolones can also be active against atypical pathogens and are used in some scenarios, the combination of macrolides or doxycycline is the classic enabling choice for these organisms. Antivirals are not appropriate because these pneumonia-causing agents are bacteria, not viruses.